Offstream
news

---

Changes

1. Polish biotechnology company Mabion S.A. signs an agreement with Novavax to start its commercial-scale production trials with U.S. pharmaceutical company for its future vaccine.
   2021-03-04 03:05:58 (First version)
2. Polish biotechnology company Mabion S.A. signs an agreement with Novavax to begin commercial-scale production trials for Novavax's future vaccine.
   (Current version)

---

Related

Novavax says that it will pursue full approval for its COVID-19 vaccine during the second half of this year.
2022-02-28

Poland indefinitely postpones its deadline of March 1 for mandatory full vaccination of teachers, members of the army and police officers, due to the current vaccination rate.
2022-02-8

Polish prime minister Mateusz Morawiecki receives a booster dose of the COVID-19 vaccine.
2021-12-1

Prime Minister Erna Solberg announces that children aged 12 to 15 years old in Norway will be offered the single-dose of the COVID-19 vaccine. However, only the Pfizer–BioNTech COVID-19 vaccine that is currently recommended for this age group.
2021-09-2

Polish Minister of Health Adam Niedzielski announces that the Supreme Medical Council has approved booster doses of the COVID-19 vaccine for people with a compromised immune system which will be administered beginning on September 1.
2021-08-27

South Korea signs an agreement with Novavax and Pfizer to secure additional doses of the COVID-19 vaccine for 23 million people in the second quarter of this year.
2021-02-16

Mexico approves the use of China's Sinovac and CanSino vaccines.
2021-02-10

Ukraine secures 12 million doses of the vaccine developed by AstraZeneca and Novavax.
2021-02-5

The Philippines signs an agreement with the Serum Institute of India to receive 30 million doses of Novavax's vaccine.
2021-01-10

South Africa is expected to begin a trial of the NVX-CoV2373, a vaccine candidate produced by Novavax. Around 2,904 volunteers are expected to be selected, who are aged from 18 to 64 years.
2020-09-5